Safety of Sinopharm vaccine in patients with congenital bleeding disorders under on-demand therapy: a preliminary report.

IF 1.1 4区医学 Q4 HEMATOLOGY Blood Coagulation & Fibrinolysis Pub Date : 2023-09-01 DOI:10.1097/MBC.0000000000001227

Amin Shahsavani, Sezaneh Haghpanah, Tahereh Zarei, Asghar Bazrafshan, Mehran Karimi

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

国药集团疫苗在按需治疗先天性出血性疾病患者中的安全性：初步报告。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Blood Coagulation & Fibrinolysis 医学-血液学

CiteScore

1.90

自引率

0.00%

发文量

111

审稿时长

4-8 weeks

期刊介绍： Blood Coagulation & Fibrinolysis is an international fully refereed journal that features review and original research articles on all clinical, laboratory and experimental aspects of haemostasis and thrombosis. The journal is devoted to publishing significant developments worldwide in the field of blood coagulation, fibrinolysis, thrombosis, platelets and the kininogen-kinin system, as well as dealing with those aspects of blood rheology relevant to haemostasis and the effects of drugs on haemostatic components

期刊最新文献

Predictive value of miR-24-3p and miR-1277-5p in hemodialysis patients with vascular access thrombosis. A new approach to personalized assessment of functional platelet disorders in children with inherited thrombocytopenias by flow cytometry. The association between the polymorphism of FXI c.539A>G and venous thromboembolism in the population of central China. Enhancing prediction of thrombosis associated with breast cancer using prechemotherapy hematologic and coagulation characteristics. Evaluation of a 4 min 4000 g centrifugation protocol for routine coagulation assays.